Project Owner | | Project City | State | Years | Value | BioMed Realty Trust Incorporated | Seattle Brownfield (Innov8) Denny Park South Life Science Complex Phase I and II | Seattle | WA | 2024-27 | $350 million |
BioMed Realty Trust Incorporated | Seattle Grassroot Dexter Yard Biomed Life Sciences Towers | Seattle | WA | 2019-22 | $250 million |
Vulcan Incorporated | Seattle Brownfield 312 Ninth Life Sciences Building | Seattle | WA | 2023-24 | $200 million |
Touchstone Corporation | Seattle Grassroot “Chapter” Life Science R&D Plant | Seattle | WA | 2022-24 | $196.2 million |
Jubilant HollisterStier LLC | Spokane Aseptic Fill/Finish & Lyophilized Vials CMO Line 4 Building Addition | Spokane | WA | 2023-26 | $193 million |
Alexandria Real Estate Equities | Seattle South BF Lake Union Brownfield Eleven50 Life Science Building | Seattle | WA | 2021-25 | $125 million |
Shape Therapeutics | Seattle Brownfield Gene/Cell Therapy/MRNA Viral Vectors CDMO | Seattle | WA | 2022-23 | $112 million |
Jubilant HollisterStier LLC | Spokane Aseptic Fill/Finish & Lyophilized Vials CMO Covid-19 Building Addition | Spokane | WA | 2021-22 | $92 million |
Just Evotec Biologics Incorporated | Redmond Grassroot Bulk Biologics Single Use CMO Plant | Redmond | WA | 2019-21 | $85 million |
AbSci Corporation | Vancouver Grassroot Biologics Antibodies and Proteins Plant | Vancouver | WA | 2021 | $85 million |